Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study

Respiratory Medicine

Volumn 104, Issue 2, 2010, Pages 253-259

  Almagro, P ^a   Lopez Garcia F ^b   Cabrera, FJ ^c   Montero, L ^d   Morchon D ^e   Diez J ^f   Soriano, JB ^g  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL VEGA BAJA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d Department of Anesthesiology   (Spain)

^e HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^f HOSPITAL ROYO VILLANOVA   (Spain)

^g Fundacion Caubet CIMERA   (Spain)

Author keywords

Cardiac failure; Comorbidity; COPD; Gender; Hospitalization

Indexed keywords

AGED; ALCOHOLISM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOTHESIS; ISCHEMIC HEART DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SPIROMETRY; STATISTICAL SIGNIFICANCE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPAIN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALCOHOLISM; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMORBIDITY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPAIN;

EID: 73749085889     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.09.019     Document Type: Article

References (32)

1. Buist A.S., McBurnie M.A., Vollmer W.M., et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370 (2007) 741-750
2. Mathers C.D., and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 11 (2006) e442
3. O'Donnell D.E., Aaron S., Bourbeau J., et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonarydisease - 2007 update. Can Respir J 14 (2007) S5-S32
4. Mannino D.M., Homa D.M., AkinBami L.J., et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 51 (2002) 1-16
5. Global Strategy for the Diagnosis. Management and Prevention of COPD, global Initiative for chronic obstructive lung disease (GOLD). [consulted 29th November 2008]. Available at (2008). http://www.goldcopd.org
6. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007) 775-789
7. Sin D.D., Anthonisen N.R., Soriano J.B., and Agustí A.G. Mortality in COPD: role of comorbidities. Eur Respir J 28 (2006) 1245-1257
8. Chatila W.M., Thomashow B.M., Minai O.A., et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5 (2008) 549-555
9. Rodriguez-Roisin S.JB. Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc 5 (2008) 842-847
10. Celli B.R., and MacNee W. American Thoracic Society / European respiratory Society Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
11. de Torres J.P., Casanova C., Hernández C., et al. Gender and COPD in patients attending a pulmonary clinic. Chest 128 (2005) 2012-2016
12. de Torres J.P., Cote C.G., López M.V., et al. Sex differences in mortality in patients with COPD. Eur Respir J 33 (2009) 528-535
13. Charlson M.E., Szatrowski T.P., Peterson J., and Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 47 (1994) 1245-1251
14. Almagro P., Calbo E., Ochoa de Echagüen A., et al. Mortality after hospitalization for COPD. Chest 121 (2002) 1441-1448
15. Torres J.P., Casanova C., Montejo de Garcini A., et al. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease. Respir Res 8 (2007) 18
16. Carrasco-Garrido P., de Miguel-Díez J., Rejas-Gutierrez J., et al. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med 9 (2009) 2-16
17. Almagro P, López García F, Cabrera FJ, et al. Estudio de las comorbilidades en pacientes hospitalizados por descompensación de EPOC atendidos en los servicios de Medicina Interna. Estudio ECCO Rev Clin Esp (in press).
18. Anthonisen N.R., Manfreda J., Warren C.P.W., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
19. Jørgensen N.R., Schwarz P., Holme I., et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101 (2007) 177-185
20. Pinckney R.G., O'Brien R.O., Piccirillo J.F., and Littenberg B. Evaluation of co-morbidity indices in patients admitted for chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 61 4 (2004) 209-212
21. Ng T.P., Niti M., Tan W.C., et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167 (2007) 60-67
22. Mannino D.M., Thorn D., Swensen A., and Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J 32 (2008) 962-969
23. Sidney S., Sorel M., Quesenberry Jr. C.P., et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical Care program. Chest 128 (2005) 2068-2075
24. Holguin F., Folch E., Redd S.C., and Mannino D.M. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128 (2005) 2005-2011
25. Render M.L., Weinstein A.S., and Blaustein A.S. Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease. Chest 107 (1995) 162-168
26. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 (2003) 1514-1519
27. Bale G., Martinez-Camblor B.PS., and Soriano J.B. Long-term mortality follow-up of the ISOLDE participants: causes of death during 13 years after trial completion. Respir Med 102 (2008) 1468-1472
28. Nishimura K., Izumi T., Tsukino M., and Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002) 1434-1440
29. Gray-Donald K., Gibbons L., Shapiro S.H., et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153 (1996) 961-966
30. Chapman K.R., Tashkin D.P., and Pye D.J. Gender bias in the diagnosis of COPD. Chest 119 (2001) 1691-1695
31. WHO Atlas of smoking worldwide 2003. At www.who.int/tobacco/statistics/tobacco_atlas/en/. Consulted 3rd March 2009.
32. García-Aymerich J., Barreiro E., Farrero E., et al. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 16 (2000) 1037-1042